Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VHT vs ETHSX overlap: 62% of top holdings shared

Bottom line

How much do VHT and ETHSX overlap?

62% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 55.4% of VHT's assets and 58.5% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.

VHT holds far more positions (407 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

VHTETHSX
Weight overlap (top 25)62%
Shared holdings13
Weight in shared holdings55.4%58.5%
Total positions40742
Expense ratio0.09%1.18%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings VHT and ETHSX have in common

Holding% of VHT% of ETHSXOverlap
Eli Lilly & Co14.04%12.47%12.47%
Johnson & Johnson8.47%6.45%6.45%
AbbVie Inc6.09%6.46%6.09%
UnitedHealth Group Inc5.45%5.49%5.45%
Merck & Co Inc4.66%5.08%4.66%
Thermo Fisher Scientific Inc2.93%2.79%2.79%
Gilead Sciences Inc2.64%3.34%2.64%
Intuitive Surgical Inc2.38%2.72%2.38%
Abbott Laboratories2.35%1.65%1.65%
Bristol-Myers Squibb Co1.84%4.25%1.84%
Vertex Pharmaceuticals Inc1.80%3.38%1.80%
Stryker Corp1.66%2.21%1.66%
Boston Scientific Corp1.13%2.18%1.13%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VHT

  1. Amgen Inc — 2.87%
  2. Pfizer Inc — 2.35%
  3. Danaher Corp — 1.84%
  4. CVS Health Corp — 1.83%
  5. Medtronic PLC — 1.50%
  6. McKesson Corp — 1.45%
  7. Elevance Health Inc — 1.35%
  8. Cigna Group/The — 1.17%
  9. Regeneron Pharmaceuticals Inc — 1.00%
  10. HCA Healthcare Inc — 0.96%
  11. Edwards Lifesciences Corp — 0.79%
  12. Cencora Inc — 0.79%

Only in ETHSX

  1. AstraZeneca PLC — 6.24%
  2. Roche Holding AG — 5.44%
  3. Sanofi SA — 2.95%
  4. Medtronic PLC — 1.80%
  5. Lonza Group AG — 1.77%
  6. Novo Nordisk A/S — 1.71%
  7. Novartis AG — 1.65%
  8. Argenx SE — 1.61%
  9. Royalty Pharma PLC — 1.58%
  10. Neurocrine Biosciences Inc — 1.41%
  11. Mettler-Toledo International Inc — 1.36%
  12. Straumann Holding AG — 1.34%

Asset mix

Asset typeVHTETHSX
Stocks99.8%99.4%
Cash & short-term funds0.2%0.3%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryVHTETHSX
US100.0%69.4%
CH—10.2%
GB—7.8%
FR—3.2%
DK—2.9%
NL—2.0%
IE—1.8%
AU—0.9%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do VHT and ETHSX overlap?
About 62% by weight. 13 securities appear in both funds' top 25 holdings; they make up 55.4% of VHT's assets and 58.5% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VHT and ETHSX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc, Merck & Co Inc.
Should I own both VHT and ETHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VHT or ETHSX?
VHT is broader, with 407 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.